Rigel Pharmaceuticals | 8-K: Current report
Apr 12 08:07 ET
Rigel Pharmaceuticals | DEFA14A: Others
Apr 10 16:53 ET
Rigel Pharmaceuticals | DEF 14A: Definitive information statements
Apr 10 16:53 ET
Rigel Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 29 17:08 ET
Rigel Pharmaceuticals | 8-K: Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Mar 5 16:18 ET
Rigel Pharmaceuticals | 8-K: Current report
Feb 22 08:01 ET
Rigel Pharmaceuticals | 8-K: Current report
Jan 8 00:00 ET
Rigel Pharmaceuticals | 8-K: Current report
Nov 30, 2023 06:04 ET
Rigel Pharmaceuticals | 8-K: Rigel Reports Third Quarter 2023 Financial Results and Provides Business Update
Nov 7, 2023 16:16 ET
Rigel Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aug 1, 2023 16:31 ET
Rigel Pharmaceuticals | 8-K: Rigel Reports Second Quarter 2023 Financial Results and Provides Business Update
Aug 1, 2023 16:15 ET
Rigel Pharmaceuticals | 8-K: Current report
May 30, 2023 16:00 ET
Rigel Pharmaceuticals | DEFR14A: Definitive proxy statement in connection with contested solicitations
May 15, 2023 16:37 ET
Rigel Pharmaceuticals | 8-K: Rigel Reports First Quarter 2023 Financial Results and Provides Business Update
May 2, 2023 16:15 ET
Rigel Pharmaceuticals | DEFA14A: Others
Apr 14, 2023 08:04 ET
Rigel Pharmaceuticals | DEF 14A: Definitive proxy statements
Apr 14, 2023 08:03 ET
Rigel Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 7, 2023 16:23 ET
Rigel Pharmaceuticals | 8-K: Rigel Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Mar 7, 2023 16:15 ET
Rigel Pharmaceuticals | 8-K: Current report
Feb 3, 2023 16:31 ET
Rigel Pharmaceuticals | 8-K: Current report
Jan 9, 2023 08:10 ET
No Data
No Data